TotalCareMedical.com

TotalCareMedical.com

Supplement Reviews

MemoHoney Review: Brain Health Total Care Assessment

Affiliate Disclosure: TotalCareMedical.com may earn a commission if you purchase through links on this page. This review is independent and based on clinical evidence standards. FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any supplement, especially if you take medications.

Clinical Summary: MemoHoney

What It Is: A once-daily capsule marketed for cognitive support and memory enhancement, sold by BuyGoods.

Key Ingredients: L-Arginine, L-Citrulline, Niacin (B3), and Beta-Alanine. Specific doses are not disclosed on the label.

Price: $79 for one bottle; tiered pricing down to $49 per bottle when buying six.

Refund Policy: 60-day money-back guarantee.

Official Site: MemoHoney official site

Clinical Evidence Level: Preliminary. Limited human cognitive trials; mostly animal and laboratory studies.

Recommended For: Adults seeking natural cognitive support with realistic expectations about current evidence.

MemoHoney's Ingredient Strategy and What Research Says

MemoHoney contains six active ingredients, but four of them work through the same biological pathway: improving blood flow via nitric oxide (NO) production and vasodilation. These are L-Arginine, L-Arginine AKG 2:1, L-Citrulline HCL, and L-Citrulline Malate.

Research suggests that increased nitric oxide and blood flow may support brain health. Animal studies show that the L-Arginine and L-Citrulline pathway could help with memory in mouse models. However, human clinical trials specifically testing cognition remain sparse.

Niacin (vitamin B3) has preliminary evidence in laboratory settings for protecting against neurodegeneration. The data comes mostly from preclinical and animal studies, not human brain health trials.

Beta-Alanine is an athletic performance supplement with established research for muscle endurance. However, there is zero evidence that Beta-Alanine supports cognitive function or brain health.

See also our analysis of Cognitive Supplement Safety Guide 2026: Interactions and ….

MemoHoney's Dosing Concerns and Formula Redundancy

The TotalCareMedical.com Health Team identified a critical issue: ingredient doses are not disclosed on the MemoHoney label. This is a red flag.

Clinical research on L-Arginine and L-Citrulline for vascular support typically uses 3 to 6 grams per dose. A single capsule cannot physically hold that amount of powder. This suggests MemoHoney doses are likely subtherapeutic—below the levels studied in research.

Additionally, including both L-Arginine and L-Arginine AKG serves the same purpose. Similarly, both L-Citrulline HCL and L-Citrulline Malate overlap in function. Four out of six ingredients all work to increase nitric oxide. This redundancy suggests formula padding rather than a thoughtfully designed blend.

MemoHoney lacks established nootropic ingredients like Bacopa Monnieri, Lion's Mane mushroom, Ginkgo Biloba, Alpha-GPC, and phosphatidylserine. These have stronger human cognitive evidence than the ingredients MemoHoney chose.

The Marketing Name Does Not Match the Formula in MemoHoney

The product is called “MemoHoney.” The name suggests honey is a key ingredient for memory support. However, MemoHoney contains zero honey.

This naming choice appears designed to trigger positive psychological associations. Honey evokes natural wellness and cognitive sharpness. The actual formula is amino acids and a B vitamin—effective compounds, but not honey-based.

The TotalCareMedical.com Health Team recommends reading ingredient labels carefully, especially when product names use emotional or associative language.

MemoHoney Pricing Tiers and the 60-Day Guarantee

Pricing starts at $79 for one bottle. Buying in bulk offers discounts: two bottles cost $158, three cost $207 ($69 per bottle), and six cost $294 ($49 per bottle).

Related reading: Memory Supplement Comparison 2026: Memora, Memopezil, Mem….

The bulk pricing structure is common in supplement marketing and may encourage larger initial purchases. The 60-day money-back guarantee allows two months to evaluate whether you notice cognitive benefits.

At the lowest bulk tier ($49 per bottle), annual cost would be approximately $588 if taken daily. Compare this against other cognitive support supplements, which typically range $30 to $80 per month.

MemoHoney's official site is available here for purchase and more details.

Who MemoHoney Is NOT For

MemoHoney carries serious drug interactions. Do not take it if you use ACE inhibitors, ARBs (angiotensin II receptor blockers), calcium channel blockers, nitrates, or PDE5 inhibitors like sildenafil. L-Arginine and L-Citrulline can dangerously lower blood pressure when combined with these medications.

People with a history of cold sores (HSV-1) should avoid high-dose L-Arginine. Research shows Arginine may trigger herpes simplex virus reactivation in susceptible individuals.

MemoHoney is not appropriate for pregnant or nursing women, children, or anyone with kidney disease. The high amino acid content requires healthy kidney function.

If you have a serious medical condition or take prescription medications, consult your doctor before starting MemoHoney.

Evidence Review: What MemoHoney Could Support and What It Cannot

Research suggests that improved blood flow and nitric oxide production may support brain function. Animal models show promise for the L-Arginine and L-Citrulline pathway in memory tasks. But human cognitive studies remain limited.

For related reading, see our review of Best Gut Health Supplements 2026: How 4 Synbiotics Compare.

Niacin evidence for brain health exists primarily in laboratory conditions, not real-world human trials. The connection to cognitive improvement is theoretical rather than clinically demonstrated.

Beta-Alanine has zero research supporting cognitive benefits. Its inclusion appears to be formula padding or a mistake in design.

No finished-product clinical trials exist for MemoHoney itself. There are no independent studies testing whether this specific formula improves memory, focus, or any cognitive measure in humans.

MemoHoney User Reports and Placebo Effects

Anecdotal user reports for MemoHoney are positive. People report feeling sharper or more focused. However, these are subjective impressions without independent verification.

Cognitive improvements are highly susceptible to placebo effect. If you expect a supplement to improve focus, your brain may feel sharper simply due to expectation—not the supplement itself. This is not a criticism; it's how human perception works.

User testimonials, pricing appeals, and brand marketing all amplify placebo. The TotalCareMedical.com Health Team recommends maintaining realistic expectations and tracking measurable outcomes if possible.

The Bottom Line on MemoHoney

MemoHoney may support cognitive function in theory, based on preliminary animal and laboratory research. The ingredients—amino acids and a B vitamin—are safe for most healthy adults and have some biological plausibility for brain health.

However, specific concerns exist. Doses are undisclosed. Four of six ingredients overlap in function, suggesting padding. No human clinical trials test MemoHoney itself. The product name is misleading. Drug interactions with blood pressure and erectile dysfunction medications are serious. And the formula lacks established nootropic ingredients with stronger human evidence.

MemoHoney is not a bad product, but it is not a clinically proven cognitive support supplement. It is a moderately researched formula with reasonable safety (for appropriate users) but limited real-world validation.

If you choose to try MemoHoney, use the 60-day refund guarantee to evaluate your own response. Track memory, focus, or energy objectively rather than relying on subjective feeling. Compare results to baseline before starting. And always consult your healthcare provider before adding any supplement, especially if you take medications.

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. MemoHoney is not intended to diagnose, treat, cure, or prevent any disease. This review is educational and not medical advice.

SodaSlim Weight Loss: Comprehensive Review 2026

Affiliate Disclosure: TotalCareMedical.com may earn a commission if you purchase SodaSlim through our links. This review is independent and educational. FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. SodaSlim is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any supplement.

Clinical Summary: SodaSlim

What It Is: A once-daily capsule designed to support weight management and metabolic function through caffeine and plant-based ingredients.

Key Ingredients: Caffeine anhydrous (138mg — disclosed), green coffee bean extract, green tea extract, garcinia extract, and raspberry ketone (individual doses undisclosed for most).

Price Range: $49–$79 per bottle depending on quantity ordered (single bottle: $79; six-bottle bundle: $294).

Refund Policy: 60-day money-back guarantee, though a 30-day trial period is required before processing returns.

Clinical Authority Note: TotalCareMedical.com Health Team notes that evidence strength varies significantly across ingredients — caffeine is research-supported, while several components lack human trial data.

Official Resource: SodaSlim official site

What Research Shows About SodaSlim's Active Ingredients

The TotalCareMedical.com Health Team examined the published evidence behind each ingredient in SodaSlim. The findings are mixed and warrant a careful, patient-centered discussion.

Caffeine anhydrous represents the strongest component. At 138 milligrams per dose, this falls squarely within the research-backed range of 100–200mg. Studies indicate that caffeine may increase metabolic rate by 3–11% in this dose window. This is the ingredient most likely to support the energy boost that roughly 40–50% of users report.

Green tea extract and green coffee bean extract appear frequently in weight management products. However, research suggests their individual effects are modest. Green tea studies show potential for 0.5–2 kilogram weight loss over 12 weeks, though much of this benefit appears linked to its caffeine content rather than unique compounds.

Garcinia extract and raspberry ketone present a different picture. Evidence indicates that garcinia (even at the stated 50% hydroxycitric acid concentration) showed no statistically significant weight loss advantage over placebo across 14 clinical trials. Raspberry ketone has zero published human studies — only animal research exists. These ingredients appear to function primarily as marketing elements rather than evidence-based additions.

SodaSlim's Pricing and Value Proposition

From a patient-centered economics perspective, pricing deserves direct attention. A single bottle costs $79 per month. Bulk discounts exist: six bottles cost $294, bringing the per-bottle price to $49.

For related reading, see our review of Nationwide Peptides GLP-3R Total Care Medical Evaluates V….

The primary active ingredient — caffeine — costs approximately $8–15 monthly when purchased as a generic supplement or even as basic over-the-counter tablets. This means users are paying a significant premium for the additional ingredients.

The 60-day refund guarantee provides some risk mitigation, though the requirement to complete a 30-day trial before requesting a return may inconvenience patients seeking quick decisions. TotalCareMedical.com Health Team recommends reviewing this timeline before purchase.

SodaSlim and Transparency: What's Missing

A critical concern involves ingredient disclosure. While caffeine's 138mg dose is stated clearly, the doses for green coffee bean extract, green tea extract, garcinia extract, and raspberry ketone remain hidden within a proprietary blend.

This opacity prevents patients and clinicians from independently assessing whether doses match those used in published research. Without disclosed amounts, it becomes impossible to verify whether these ingredients appear in therapeutic quantities or merely token amounts.

Additionally, SodaSlim's marketing emphasizes “gut bacteria targeting,” yet the product contains zero probiotic ingredients. The product includes no Lactobacillus, Bifidobacterium, or other documented beneficial strains. This disconnect between marketing claims and actual formulation raises transparency concerns that TotalCareMedical.com Health Team considers important for informed decision-making.

The manufacturer remains undisclosed on publicly available information. BuyGoods is listed as the seller, but the actual producer is not named, complicating quality assurance verification.

Who May Experience Benefits From SodaSlim

Research suggests that caffeine-sensitive individuals without existing cardiac issues may notice increased energy and focus within 30–60 minutes of taking SodaSlim. This aligns with the 40–50% of users reporting energy boost in real-world outcomes.

People seeking a single daily capsule rather than managing multiple supplements may appreciate the convenience factor. The once-daily format appeals to patients prioritizing simplicity in their supplement routine.

See also our analysis of Best Gut Health Supplements 2026: How 4 Synbiotics Compare.

Individuals already consuming 0–100mg of daily caffeine may perceive the 138mg addition as meaningful. For those already consuming 200+ mg from coffee or tea, the incremental benefit diminishes substantially.

Who SodaSlim Is NOT For

Patients with cardiac arrhythmias, uncontrolled hypertension, or caffeine sensitivity should avoid SodaSlim without explicit physician approval. The 138mg caffeine dose is not trivial for sensitive populations.

Pregnant and breastfeeding individuals should not use SodaSlim. Caffeine crosses the placental barrier and concentrates in breast milk, creating fetal and neonatal risks.

Anyone expecting significant weight loss should recalibrate expectations. Even the most optimistic research suggests modest effects — typically under 2 kilograms over 12 weeks when combined with dietary changes. SodaSlim is not a substitute for caloric deficit and physical activity.

Patients relying on medication interactions must consult their doctor. Caffeine and certain plant extracts interact with blood pressure medications, anticoagulants, and psychiatric medications.

Budget-conscious individuals may question the $49–79 monthly expense for an ingredient list 80% of which lacks strong human evidence.

The Real-World User Experience With SodaSlim

Outcome data from actual users tells an important story. Approximately 40–50% report energy boost and mild appetite reduction. This suggests a respectable but not overwhelming response rate.

The inverse is equally telling: 50–60% report no meaningful effect. For individuals in this category, SodaSlim represents a $49–79 monthly expense with negligible benefit.

Related reading: Retatrutide Alternative: Comprehensive Review of Free Gov….

TotalCareMedical.com Health Team emphasizes that individual biochemistry varies. Some patients metabolize caffeine rapidly and feel minimal impact; others experience pronounced alertness. Genetics and baseline caffeine consumption heavily influence outcomes.

SodaSlim Versus Lifestyle Approaches: A Clinical Perspective

The TotalCareMedical.com Health Team must highlight what research consistently demonstrates: sustainable weight management depends primarily on dietary patterns and physical activity. No supplement—including SodaSlim—replaces these fundamentals.

Caffeine may provide a modest metabolic boost, but studies suggest this effect plateaus at 3–11% and diminishes over time as tolerance develops. Over 12 weeks, this might contribute to 1–3 additional pounds of loss when combined with caloric restriction.

Structured exercise, increased protein intake, and sleep optimization produce far larger effects than any supplement alone. SodaSlim could potentially serve as a minor adjunct to these cornerstone behaviors, not as a primary intervention.

The Bottom Line on SodaSlim

SodaSlim contains one research-supported ingredient (caffeine) at an evidence-based dose. For approximately 40–50% of users, this translates to noticeable energy and mild appetite effects. However, the product also includes ingredients with weak or absent human evidence, wrapped in a proprietary blend that prevents independent verification.

The $49–79 monthly price point significantly exceeds the cost of purchasing caffeine or green tea extract independently. This premium reflects marketing, branding, and convenience—not superior efficacy.

If you prioritize simplicity, tolerate caffeine well, and can afford the cost without financial strain, SodaSlim may be worth a 30-day trial using the money-back guarantee. However, it should never replace established weight management pillars: caloric deficit, regular exercise, sleep, and stress management.

For detailed product information and to review current pricing, visit the SodaSlim official site. Always discuss new supplements with your primary care provider, particularly if you have existing health conditions or take medications.

This review represents an independent assessment by the TotalCareMedical.com Health Team based on available clinical evidence and product disclosures. Results vary individually. These statements have not been evaluated by the Food and Drug Administration, and this product is not intended to diagnose, treat, cure, or prevent any disease.

Nationwide Peptides GLP-3R Review 2026: Total Care Medical Evaluates Vendor Purity Claims

Disclaimer: This article is for informational purposes only and does not constitute medical advice. GLP-3R is a research peptide sold for laboratory use only — it is not intended for human consumption. These statements have not been evaluated by the FDA. Always consult your healthcare provider.

Clinical Summary: Nationwide Peptides GLP-3R

What It Is: Research peptide — triple-agonist targeting GLP-1, GIP, and glucagon receptors
Vendor: Nationwide Peptides — claims ≥99% purity with COA; no Finnrick-verified independent testing on record
Testing: Vendor-provided COA with HPLC, MS, amino acid analysis; no independent third-party verification found
Price: $44-$306 (5mg-60mg vials); ~$8.80/mg at 5mg
Key Concern: No independent testing verification; limited community feedback; not FDA-approved; research-only
Who It's For: Qualified researchers investigating triple-receptor agonist peptide biology

Understanding GLP-3R: Nationwide Peptides' Triple-Receptor Research Compound

Nationwide Peptides' GLP-3R represents a synthetic 39-amino-acid research peptide designed to modulate three distinct biological pathways simultaneously. As a triple-agonist targeting the GLP-1 receptor, glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR), this compound mirrors the pharmacological profile of Eli Lilly's retatrutide (LY3437943), currently advancing through Phase 3 clinical development. For researchers and clinical observers monitoring the peptide landscape, understanding GLP-3R's mechanism and vendor positioning offers valuable context about emerging multi-receptor approaches in metabolic research.

The theoretical advantage of a triple-agonist lies in its expanded receptor coverage compared to existing research compounds. Semaglutide targets a single receptor (GLP-1R), while tirzepatide engages two receptors (GLP-1R and GIPR). GLP-3R's three-receptor approach may offer enhanced biological activity, though this remains an area of active investigation. Phase 3 TRIUMPH trial data from Eli Lilly's retatrutide indicated approximately 28–30% body weight reduction over 68–80 weeks, substantially higher than the approximately 15% reduction observed with semaglutide and the approximately 22% reduction documented with tirzepatide. These preliminary findings have generated considerable interest in the research community regarding multi-receptor peptide therapeutics.

Nationwide Peptides' Purity Claims and Certificate of Analysis Documentation

Nationwide Peptides advertises GLP-3R at ≥99% purity, with supporting documentation that includes HPLC (High-Performance Liquid Chromatography), mass spectrometry, and amino acid analysis. The company claims GMP (Good Manufacturing Practice) synthesis and lyophilized powder formulation, suggesting adherence to pharmaceutical manufacturing standards. These vendor-provided certificates of analysis represent a foundational commitment to quality control that may be relevant for research applications requiring consistent, well-characterized compounds.

The acetate salt form includes proprietary modifications, indicating vendor-level customization beyond standard peptide synthesis. The availability of eight vial sizes—ranging from 5mg ($44) at entry level to 60mg ($306) at maximum—suggests established manufacturing infrastructure capable of scaling production across multiple dose formats. Pricing at approximately $8.80 per milligram for the 5mg vial positions Nationwide Peptides within mid-range market rates for research-grade peptides, making the offering accessible for laboratory-scale investigations.

The Critical Transparency Gap: Vendor-Provided vs. Independent Verification

A significant distinction emerges between Nationwide Peptides' internal testing claims and independent third-party verification. The company's certificates of analysis derive from vendor-controlled testing—HPLC, mass spectrometry, and amino acid analysis performed by Nationwide Peptides or their direct laboratory partners. Notably, GLP-3R does not appear on Finnrick Analytics, the leading independent verification platform for research compound quality assessment. This absence means no external, arms-length validation exists on public record to corroborate the ≥99% purity claims or confirm GMP synthesis standards.

For researchers prioritizing transparency and independent verification, this represents a meaningful gap. Competitors offering Finnrick-verified testing provide an additional layer of credibility that may reduce uncertainty about compound quality and consistency. While vendor certifications offer baseline assurance and suggest good-faith quality commitment, independent verification allows researchers to cross-validate vendor claims against neutral laboratory findings. The lack of Finnrick documentation does not necessarily indicate substandard quality; rather, it reflects a choice not to pursue third-party independent testing or a recent market entry that has not yet established such verification pathways.

Market Positioning and Community Visibility

Nationwide Peptides' market presence remains relatively limited in visible research communities. No significant Reddit discussions, independent review aggregations, or peer commentary appears to document user experiences or feedback regarding their GLP-3R product. This limited track record visibility contrasts with more established vendors in the research peptide space who have generated community discussion and accumulated user-reported data over extended periods. The absence of community feedback neither confirms nor refutes product quality; it simply indicates that independent evaluation and discussion forums have not yet incorporated this vendor's offerings into broadly accessible repositories.

The company's tagline—”Unmatched Purity. Unlimited Potential”—reflects confident positioning, yet marketing claims require substantiation through independent verification and sustained market performance. Researchers evaluating Nationwide Peptides may benefit from direct contact at (844) 480-0111 or support@nationwidepeptides.com to request additional documentation, clarify testing methodologies, and understand their quality assurance protocols beyond standard COA presentation.

Storage Requirements and Handling Specifications

GLP-3R storage recommendations reflect standard peptide stability protocols: -20°C freezer storage for long-term preservation, with short-term refrigeration at 2–8°C (standard refrigerator conditions) acceptable for brief periods. These specifications suggest lyophilized powder formulation, which typically offers superior stability compared to liquid solutions. Proper storage adherence becomes critical for maintaining the claimed ≥99% purity throughout the compound's shelf life, particularly if extended storage or multiple access cycles occur. Researchers should maintain detailed storage logs and temperature monitoring to ensure compliance with manufacturer guidelines.

Clinical Trial Context: Retatrutide's Phase 3 Safety Profile and Efficacy Data

Eli Lilly's retatrutide clinical program provides essential context for understanding GLP-3R's research rationale. Phase 3 TRIUMPH trials documented substantial weight reduction alongside a recognizable adverse event profile. Gastrointestinal symptoms—particularly nausea and vomiting—occurred in approximately 25–30% of trial participants. Additional reported effects included paresthesia (peripheral nerve sensations) and elevated heart rate. These safety signals, while manageable in controlled clinical settings, underscore that multi-receptor agonism generates broader physiological effects than single-receptor compounds. FDA approval of pharmaceutical retatrutide remains anticipated around 2027, meaning clinical development continues and the long-term safety-efficacy profile may evolve as additional data accumulate.

For researchers, this data landscape means that GLP-3R represents an investigational tool modeling a compound still in human development. Research findings generated with Nationwide Peptides' GLP-3R may contribute to broader understanding of triple-agonist pharmacology, but direct clinical translatability remains uncertain until pharmaceutical retatrutide completes approval pathways.

Balanced Assessment: Strengths, Limitations, and Research Considerations

Nationwide Peptides presents GLP-3R as a high-purity, comprehensively characterized research peptide backed by internal documentation and GMP manufacturing claims. The vendor's established product range (5–60mg vials), mid-market pricing, and willingness to provide detailed certificates of analysis suggest operational competence and customer-focused service. Free shipping on orders exceeding $200 and multiple contact channels enhance accessibility for research institutions.

However, the absence of independent third-party verification through established platforms like Finnrick Analytics creates an evaluative limitation. Researchers prioritizing maximum transparency may prefer vendors offering Finnrick-verified testing or other recognized independent assessment. The limited community discussion and lack of user-reported experience data mean that Nationwide Peptides' track record remains relatively opaque compared to longer-established competitors in the research peptide market.

GLP-3R remains a research-only compound, explicitly not intended for human consumption. Its theoretical advantages stem from triple-receptor activation, mirroring Eli Lilly's clinical-stage retatrutide, yet clinical validation in humans remains incomplete. Researchers considering GLP-3R should evaluate it within the context of their specific research objectives, quality assurance standards, and institutional compliance requirements. Direct inquiry with Nationwide Peptides regarding testing methodology details, batch traceability, and quality control protocols may provide additional confidence for institutions with heightened verification standards.

Compare Other GLP-3R Triple-Agonist Vendors

This review is part of our ongoing evaluation of research-grade retatrutide (GLP-3R) vendors. For a complete picture, see how other suppliers compare:

Each vendor review examines purity testing, dosage accuracy, pricing, and transparency — the factors that matter most for research-grade peptide procurement.

These statements have not been evaluated by the FDA. GLP-3R is a research peptide not intended for human consumption. Always consult a qualified healthcare provider before considering any research compounds.

ColestZen Dosage Guide 2026: What the Label Says (and the Transparency Gap About Ingredient Amounts)

This article may contain affiliate links. TotalCareMedical.com may earn a commission on purchases made through these links, at no additional cost to you. This does not influence our health evaluations.

“`html

Total Care Medical provides independent health supplement reviews for educational purposes. We do not endorse products or make medical claims. Always consult your doctor before starting any new supplement, especially if you take prescription medications or have existing health conditions. This review reflects product information available as of July 2026.

Clinical Summary: ColestZen

  • What It Is: 18-ingredient daily supplement (9 botanicals + 9 micronutrients) targeting cholesterol, blood sugar, and circulation support
  • Serving Size: 2 capsules daily
  • Key Ingredients: Bitter Melon, Cinnamon Bark, Gymnema Sylvestre, Banaba Leaf, Licorice Root, Mulberry Fruit, Cayenne Pepper, Yarrow, Juniper Berry, L-Taurine, Alpha Lipoic Acid, Vitamin C, Vitamin E, Biotin, Magnesium, Zinc, Manganese, Chromium
  • Price: $49–$79/bottle depending on bundle size
  • Guarantee: 60-day money-back (buyer covers return shipping)
  • Official Site: trycolestzen.com
  • Customer Support: support@trycolestzen.com | (305) 457-6427 | Mon–Fri 9am–6pm ET
  • Key Concern: Per-ingredient dosages not disclosed on label
  • Who It May Suit: Adults 35+ seeking daily support alongside (not replacing) existing care

July 2026 Update: ColestZen has now disclosed its full 18-ingredient formula for the first time via a syndicated press release. This article has been updated with confirmed ingredient data, pricing, and guarantee information. Key finding: all 18 ingredients are named, but per-ingredient amounts remain undisclosed—a critical transparency gap that makes it impossible to assess whether doses are therapeutic or sub-therapeutic.

What Is ColestZen?

ColestZen is a capsule-based dietary supplement made for adults over 35 who want daily nutritional support for cholesterol balance, blood sugar levels, and healthy circulation. The standard dosing instruction is straightforward: take 2 capsules daily with water, typically with a meal. The formula contains 18 different ingredients organized into two layers—nine plants or plant extracts plus nine vitamins and minerals. The manufacturer claims this combination works together to help your body maintain healthy cholesterol levels and stable blood sugar naturally.

The product is sold through BuyGoods, a Delaware corporation, with fulfillment handled by JetPack from their facility in Tallmadge, Ohio. As noted in a recent consumer interest analysis, adults searching for cholesterol support alternatives have shown growing interest in multi-ingredient formulas like this one. The brand claims over 12,785 five-star reviews, though the actual review platform is not publicly disclosed—which is a transparency gap worth noting.

The 18-Ingredient Formula: Confirmed Breakdown

For the first time, ColestZen disclosed all 18 ingredients in a syndicated press release dated July 24, 2026. Here's the complete formula organized by category:

Botanical Ingredients (9):

  • Bitter Melon Extract (fruit)
  • Cinnamon (bark)
  • Licorice Extract (root)
  • Gymnema Sylvestre Powder (leaf)
  • Banaba Extract (leaf)
  • Mulberry Fruit Powder
  • Yarrow Herb Powder
  • Cayenne Pepper Extract
  • Juniper Berry Powder

Micronutrients (9):

  • L-Taurine
  • Alpha Lipoic Acid
  • Vitamin C
  • Vitamin E
  • Biotin
  • Magnesium
  • Zinc
  • Manganese
  • Chromium

Breaking Down the Ingredients: Two Layers Explained

ColestZen uses what the manufacturer calls a “two-layer” approach: nine botanical ingredients and nine micronutrients (vitamins and minerals). Understanding what each layer does helps you evaluate whether this formula aligns with your health goals.

The Botanical Layer (Plant-Based Ingredients)

Bitter Melon Extract comes from a tropical fruit. Some users report it may help support healthy blood sugar levels, though human studies remain limited. Cinnamon Bark is a widely studied spice. Research suggests cinnamon may support cholesterol balance and blood sugar control, making it a popular choice in formulas like this.

Gymnema Sylvestre is an herb used in traditional Indian medicine. The name literally means “sugar destroyer,” and some research shows it may help reduce sugar cravings and support blood sugar management. Banaba Leaf Extract contains a compound called corosolic acid, which early research suggests might support glucose metabolism (how your body processes sugar).

Mulberry Fruit Powder is rich in antioxidants (compounds that protect cells from damage). Some studies indicate mulberry may support cholesterol levels and blood sugar stability. Licorice Root Extract is an ancient remedy used for centuries. It may support digestion and help regulate blood sugar, though it should be used cautiously by people with high blood pressure.

Cayenne Pepper Extract contains capsaicin, the compound that makes peppers hot. Research shows capsaicin may support healthy circulation and metabolism. Yarrow Herb Powder and Juniper Berry Powder round out the botanical blend. Both have traditional uses, though modern human studies on these two ingredients are sparse compared to the others.

The Micronutrient Layer (Vitamins and Minerals)

The second half of ColestZen's formula includes vitamins and minerals that support overall metabolic health. Vitamin C is essential for immune function and acts as an antioxidant. Vitamin E is another powerful antioxidant that may support heart health.

Biotin is a B-vitamin that supports healthy skin, hair, and nail growth—and may help your body process carbohydrates (sugars and starches) more efficiently. Chromium is a trace mineral (a mineral your body needs in very small amounts) that plays a key role in how your body handles blood sugar. Several studies show chromium supplementation may support healthy glucose metabolism.

Alpha Lipoic Acid (also called ALA) is a compound made naturally by your cells. It acts as an antioxidant and may support blood sugar balance and nerve health. L-Taurine is an amino acid (building block of protein) that may support heart and muscle function. Magnesium, Zinc, and Manganese round out the micronutrient blend—all essential minerals involved in energy production and metabolic health.

What Does Research Actually Show?

This is where you need to be clear-eyed. While ColestZen lists 15 scientific citations supporting its ingredients, the formula itself has no published clinical trials. This means no independent study has tested ColestZen specifically to measure how well it works in real people.

However, research on individual ingredients does exist. Cinnamon, chromium, and bitter melon have the strongest evidence for supporting blood sugar balance. Cinnamon bark, in particular, appears in numerous peer-reviewed studies showing it may help support healthy cholesterol levels. Gymnema and banaba leaf also have some supporting research, though the evidence is less robust than for cinnamon.

The micronutrient ingredients—especially chromium and alpha lipoic acid—have solid research backing their role in glucose metabolism and metabolic support. What's important to understand: supporting individual ingredients is not the same as proving the whole formula works. When you combine 18 ingredients, you cannot simply add up their individual benefits. Interactions between ingredients are complex, and manufacturers don't always disclose how much of each ingredient is in every capsule.

The Critical Transparency Gap: Missing Per-Ingredient Dosages

This is ColestZen's biggest weakness. Although the label now names all 18 ingredients, it does not disclose how much of each ingredient you're getting per serving. You know the formula contains bitter melon, cinnamon, chromium, and the others—but you don't know the exact amounts in each 2-capsule serving.

This matters significantly. Some ingredients (like licorice) require dose limits to be safe over long-term use. Other ingredients (like chromium or alpha lipoic acid) have established therapeutic ranges in clinical research. Without knowing the actual dosages, you cannot independently verify whether you're getting clinically meaningful amounts or just trace amounts that may have little practical effect.

For example, chromium supplementation in clinical studies typically ranges from 200–400 mcg daily. Cinnamon bark extract has shown benefits in studies using 1–3 grams daily. Alpha lipoic acid studies often use 300–600 mg daily. Without disclosure of per-ingredient amounts, it's impossible to compare ColestZen's formula to these established research doses and assess dosage adequacy.

Transparency in supplement labeling is a hallmark of quality brands. When manufacturers disclose full amounts on the Supplement Facts label, it signals confidence in their formulation and allows healthcare providers and consumers to make informed decisions. This omission is a red flag worth considering, especially if you plan to use this supplement long-term or alongside other medications.

Pricing and Value: Should You Buy in Bulk?

ColestZen offers three pricing tiers:

  • Single bottle (one month): $79
  • Three-bottle bundle: $69 per bottle ($207 total)
  • Six-bottle bundle: $49 per bottle ($294 total) plus free US shipping and two bonus guides

The six-bottle option saves you the most money per bottle, but it requires a $294 upfront commitment. If you're trying this product for the first time, start with a single bottle or the three-bottle bundle. This way, you can assess how your body responds before committing to six months of supply.

At $49–$79 per month, ColestZen falls in the mid-range for multi-ingredient supplement formulas. You're paying for convenience (one formula with 18 ingredients) rather than buying each ingredient separately. Whether that's a good value depends on whether it actually works for your body—which brings us to the guarantee.

The Money-Back Guarantee: What You Need to Know

ColestZen offers a 60-day money-back guarantee. This sounds good, but read the fine print: you must cover the cost of return shipping. Depending on where you live, return shipping could cost $10–$20. The company also takes 3–5 business days to process refunds after receiving your return.

The guarantee is genuine, but it's not risk-free. If you're unhappy after 60 days, you'll eat some costs and wait for your money. Make sure you actually use the product consistently during those 60 days before deciding it doesn't work.

Safety, Side Effects, and Drug Interactions

ColestZen is made in an FDA-registered, GMP-certified facility (GMP means “good manufacturing practices,” a quality standard for supplements). This doesn't mean the FDA has approved the formula itself—dietary supplements don't require FDA approval before sale—but it does mean the facility meets safety and cleanliness standards.

Most users report tolerating the formula well. However, some ingredients can cause side effects or interactions. Licorice root may raise blood pressure if used long-term, especially in people who already have hypertension (high blood pressure). Cayenne pepper can upset your stomach if you have a sensitive digestive system. Chromium may interact with insulin or diabetes medications, so discuss this supplement with your doctor if you take any blood sugar medications.

If you're pregnant, nursing, or taking prescription medications—especially cholesterol drugs like statins or blood sugar medications like metformin—talk to your doctor before starting ColestZen. Supplements can interact with medications in ways that reduce effectiveness or cause harm.

Who Should NOT Use ColestZen

ColestZen is NOT a replacement for prescribed cholesterol or blood sugar medications. If your doctor has prescribed statin drugs or diabetes medications, keep taking them. Do not stop your medications to try a supplement.

Avoid ColestZen if you:

  • Are pregnant or breastfeeding
  • Have a history of kidney disease or liver disease
  • Take blood thinners (like warfarin) without doctor approval
  • Have uncontrolled high blood pressure and use licorice-containing products regularly
  • Are allergic to any of the 18 ingredients
  • Have severe digestive problems triggered by spicy foods or herbal supplements

If you fall into any of these categories, consult your healthcare provider before use.

Bottom Line: Is ColestZen Right for You?

ColestZen is a thoughtfully formulated supplement with ingredients that research supports for cholesterol and blood sugar support. The formula itself is untested in clinical trials, and the lack of disclosed per-ingredient dosages is a real weakness. It's not a magic pill—it's a daily support tool that may help alongside diet, exercise, and existing medical care.

ColestZen makes sense if: You're 35 or older, want comprehensive daily support for cholesterol and blood sugar health, are willing to commit to consistent use of 2 capsules daily for at least 60 days, and have consulted your doctor about ingredients and potential interactions.

Skip ColestZen if: You're looking for a replacement for prescription medications, expect dramatic results without lifestyle changes, want full transparency on every ingredient dose, or have a history of drug interactions with herbal supplements.

The 60-day guarantee gives you a reasonable window to test whether this formula works for your body. Start with the single bottle or three-bottle option, stay consistent with the daily 2-capsule dosing, and track how you feel. Work with your doctor to check your cholesterol and blood sugar levels after 8–12 weeks to see whether this supplement is actually delivering results for you personally.

Related Articles

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This review is educational only and does not replace professional medical advice. Always consult a healthcare provider before starting any supplement.


“`

Peptide Sciences GLP-3R Review 2026: Total Care Medical Analyzes 41-Test Vendor Record

Disclaimer: This article is for informational purposes only and does not constitute medical advice. GLP-3R is a research peptide sold for laboratory use only — it is not intended for human consumption. These statements have not been evaluated by the FDA. Always consult your healthcare provider.

Clinical Summary: Peptide Sciences GLP-3R

What It Is: Research peptide — triple-agonist targeting GLP-1, GIP, and glucagon receptors
Vendor: Peptide Sciences — Finnrick #1 by test volume (41 tests), but only 56% rating with 51% pass rate
Testing: 41 independent tests: 21 passed, 20 failed; identity failures (0 mg detected), overfills (+45%), purity 99.0-99.4%
Price: $17.92/mg median
Key Concern: Repeated identity failures; erratic batch quality; not FDA-approved; research-only
Who It's For: Qualified researchers investigating triple-receptor agonist peptide biology

Understanding Retatrutide: The Triple-Agonist Research Peptide

Retatrutide has emerged as one of the most anticipated research peptides in metabolic science, representing a significant departure from earlier generations of weight-management compounds. Unlike semaglutide, which targets a single receptor (GLP-1R), or tirzepatide, which engages two receptors (GLP-1R and GIPR), retatrutide functions as a triple-agonist—simultaneously activating GLP-1R, GIPR (glucose-dependent insulinotropic polypeptide receptor), and GCGR (glucagon receptor). This triadic mechanism of action may explain why Eli Lilly's pharmaceutical retatrutide (LY3437943) has demonstrated approximately 28–30% body weight reduction over 68–80 weeks in Phase 3 TRIUMPH trials, substantially outpacing the ~15% reduction observed with semaglutide and the ~22% with tirzepatide. Peptide Sciences offers a research-grade synthetic 39-amino-acid retatrutide peptide, but independent testing reveals significant quality control challenges that warrant careful scrutiny before any research consideration.

Peptide Sciences' Testing Volume and the Quality Paradox

Peptide Sciences holds a distinctive position in the retatrutide research market: the vendor has undergone more independent laboratory testing than any competitor, with 41 documented tests on record between June 2025 and July 2026 according to Finnrick Analytics. This extensive testing volume earned the company a “#1 by testing volume” ranking among 223 retatrutide vendors—a distinction that initially suggests comprehensive quality assurance. However, the underlying data reveals a troubling paradox. Of those 41 tests, only 21 passed, yielding a 51% pass rate. Peptide Sciences' overall Finnrick score for retatrutide is 56%, placing it among the lower-performing vendors despite the sheer quantity of testing. This apparent contradiction suggests that high test volume does not automatically correlate with batch consistency or reliability. The broader picture is more concerning: across all products, Peptide Sciences receives a vendor rating of only 61%, ranking #241 of 274 competitors—a position indicating systemic quality control issues that extend beyond retatrutide alone.

Identity Failures and the Most Critical Quality Concern

Among the failed tests, the most alarming findings involve repeated identity failures, where some samples returned 0 mg of detectable retatrutide. This outcome—where a vial contains essentially no active peptide—represents the most serious red flag for any research compound. Identity failures suggest that some batches may have been mislabeled, improperly manufactured, or subjected to degradation during storage or shipment. For researchers relying on consistent, verified peptide composition, such failures render data collection unreliable and potentially wasteful. The erratic pattern of these failures, combined with post-shutdown public testing data from spring 2026 that show both sudden failures and later recoveries, indicates potential supply chain inconsistency or manufacturing variability rather than isolated incidents. Traceability gaps—with many samples lacking proper batch identification—compound the concern, making it difficult to trace root causes or predict which future batches might be affected.

Purity, Overfilling, and Manufacturing Consistency Issues

When retatrutide is present in Peptide Sciences samples, purity typically clusters around 99.0–99.4%—adequate for many research applications but inconsistently falling short of the 99.5%+ standard that research-grade peptides should maintain. Beyond identity and purity, independent testing has documented significant overfilling problems, with some batches containing +45–46% more peptide than labeled. Overfilling creates multiple problems: it renders dose calculations unreliable for researchers, suggests imprecise manufacturing processes, and may indicate inadequate quality control checkpoints. Combined with the purity inconsistencies and identity failures, these overfilling instances paint a picture of manufacturing operations that may lack sufficient process controls. The fact that Peptide Sciences demonstrates better performance on other peptides—with semaglutide testing at 81% pass rates and GHK-Cu at 92%—suggests the retatrutide quality issues may be product-specific rather than reflecting across-the-board manufacturing deficiency. This distinction is important: it could indicate supply chain problems specific to retatrutide sourcing, manufacturing expertise gaps with this particular triple-agonist structure, or batch-to-batch variability in the synthetic process.

Comparative Performance and Vendor Reliability Assessment

Context matters when evaluating Peptide Sciences' retatrutide offerings. The vendor's stronger performance on other research peptides—particularly semaglutide at 81% pass rate and GHK-Cu at 92%—demonstrates that the company has capability for quality control. Conversely, other products show poor results (CJC-1295 at 16%, Tesamorelin at 40%), suggesting selective quality problems. At $17.92 per milligram (median pricing), Peptide Sciences' retatrutide is neither premium-priced nor budget-tier, but the pricing does not justify the 51% pass rate or identity failure risks. Customer ratings of 4.3 stars across 12 reviews appear positive on the surface, but such ratings may reflect general satisfaction with customer service rather than peptide purity or potency. For researchers considering retatrutide from Peptide Sciences, the reality is that while the company has invested in testing visibility, the actual results warrant skepticism. A 51% pass rate means that a researcher has roughly a 50-50 chance of receiving a batch that meets quality specifications—odds that would be unacceptable in clinical or rigorous pre-clinical research contexts.

The Retatrutide Research Landscape and FDA Timeline

Retatrutide remains a research peptide with no current FDA approval for human use. Eli Lilly's pharmaceutical-grade retatrutide is expected to achieve FDA approval around 2027, at which point the regulatory landscape will shift dramatically. Clinical trial data from Eli Lilly's Phase 3 TRIUMPH studies has documented side effects including gastrointestinal disturbances (nausea and vomiting in approximately 25–30% of participants), paresthesia, and elevated heart rate—profile considerations that apply to any retatrutide investigation. For researchers working with synthetic research-grade peptides like Peptide Sciences' offering, these pharmacological profiles inform mechanistic understanding but do not translate to human safety data, as research peptides are explicitly not intended for human consumption. The distinction is critical: pharmaceutical-grade retatrutide will undergo rigorous manufacturing, stability testing, and quality assurance under FDA oversight, whereas research peptides operate in an entirely different regulatory framework with significantly less oversight.

Balanced Assessment: Should Researchers Consider Peptide Sciences' Retatrutide?

For researchers requiring retatrutide for legitimate pre-clinical investigation, Peptide Sciences presents both advantages and substantial risks. The advantage is transparent testing data—41 independent tests provide more visibility than many competitors offer, and the vendor's stronger performance on other peptides suggests selective capability. The risks, however, are substantial: a 51% pass rate, documented identity failures (zero-detection events), overfilling inconsistencies, and erratic batch quality from spring 2026 onward. These factors suggest that researchers using Peptide Sciences' retatrutide could encounter vials with no active peptide, incorrect dosing due to overfilling, or variable purity that compromises experimental reproducibility. For rigorous research requiring reliable, consistent peptide composition, these issues are disqualifying. Researchers with less stringent requirements—such as preliminary exploratory work where exact dosing is less critical—might find the testing transparency informative, though the 51% pass rate remains concerning. The fundamental question is whether the cost savings of Peptide Sciences' pricing ($17.92/mg) justifies the quality control risks. For most serious research applications, the answer is likely no. Higher-performing vendors or direct pharmaceutical-grade sources would provide superior reliability, though at potentially higher cost or with different access constraints.

Compare Other GLP-3R Triple-Agonist Vendors

This review is part of our ongoing evaluation of research-grade retatrutide (GLP-3R) vendors. For a complete picture, see how other suppliers compare:

Each vendor review examines purity testing, dosage accuracy, pricing, and transparency — the factors that matter most for research-grade peptide procurement.

These statements have not been evaluated by the FDA. GLP-3R is a research peptide not intended for human consumption. Always consult a qualified healthcare provider before considering any research compounds.